Global Molecular Diagnostics in Cancer Testing Sales Market Report 2017

Global Molecular Diagnostics in Cancer Testing Sales Market Report 2017

1 Molecular Diagnostics in Cancer Testing Overview

1.1 Product Overview and Scope of Molecular Diagnostics in Cancer Testing

1.2 Classification of Molecular Diagnostics in Cancer Testing

1.2.1 Type I

1.2.2 Type II

1.3 Application of Molecular Diagnostics in Cancer Testing

1.3.1 Application 1

1.3.2 Application 2

1.4 Molecular Diagnostics in Cancer Testing Market by Regions

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 Japan Status and Prospect (2012-2022)

1.4.5 Southeast Asia Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Molecular Diagnostics in Cancer Testing (2012-2022)

1.5.1 Global Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2022)

1.5.2 Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

2 Global Molecular Diagnostics in Cancer Testing Competition by Manufacturers, Type and Application

2.1 Global Molecular Diagnostics in Cancer Testing Market Competition by Manufacturers

2.1.1 Global Molecular Diagnostics in Cancer Testing Sales and Market Share of Key Manufacturers (2012-2017)

2.1.2 Global Molecular Diagnostics in Cancer Testing Revenue and Share by Manufacturers (2012-2017)

2.2 Global Molecular Diagnostics in Cancer Testing (Volume and Value) by Type

2.2.1 Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Type (2012-2017)

2.2.2 Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)

2.3 Global Molecular Diagnostics in Cancer Testing (Volume and Value) by Regions

2.3.1 Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Regions (2012-2017)

2.3.2 Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Regions (2012-2017)

2.4 Global Molecular Diagnostics in Cancer Testing (Volume) by Application

3 United States Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)

3.1 United States Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)

3.1.1 United States Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

3.1.2 United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

3.1.3 United States Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

3.2 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers

3.3 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Type

3.4 United States Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

4 China Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)

4.1 China Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)

4.1.1 China Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

4.1.2 China Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

4.1.3 China Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

4.2 China Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers

4.3 China Molecular Diagnostics in Cancer Testing Sales and Market Share by Type

4.4 China Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

5 Europe Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)

5.1 Europe Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)

5.1.1 Europe Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

5.1.2 Europe Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

5.1.3 Europe Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

5.2 Europe Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers

5.3 Europe Molecular Diagnostics in Cancer Testing Sales and Market Share by Type

5.4 Europe Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

6 Japan Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)

6.1 Japan Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)

6.1.1 Japan Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

6.1.2 Japan Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

6.1.3 Japan Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

6.2 Japan Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers

6.3 Japan Molecular Diagnostics in Cancer Testing Sales and Market Share by Type

6.4 Japan Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

7 Southeast Asia Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)

7.1 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)

7.1.1 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

7.2 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers

7.3 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Market Share by Type

7.4 Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

8 India Molecular Diagnostics in Cancer Testing (Volume, Value and Sales Price)

8.1 India Molecular Diagnostics in Cancer Testing Sales and Value (2012-2017)

8.1.1 India Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

8.1.2 India Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

8.1.3 India Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

8.2 India Molecular Diagnostics in Cancer Testing Sales and Market Share by Manufacturers

8.3 India Molecular Diagnostics in Cancer Testing Sales and Market Share by Type

8.4 India Molecular Diagnostics in Cancer Testing Sales and Market Share by Application

9 Global Molecular Diagnostics in Cancer Testing Manufacturers Analysis

9.1 Abbott Molecular Diagnostics

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Accugenomics

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Agendia

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Agendia Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Ambry Genetics

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Biodesix

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Biodesix Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 bioMerieux

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 bioTheranostics (AviaraDx)

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Cancer Genetics

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Clarient, Inc. (GE Healthcare)

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Counsyl

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Counsyl Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Flatiron Health

9.12 Epigenomics

9.13 Exact Sciences Corporation

9.14 Exiqon

9.15 Genomic Health

9.16 Genoptix (Novartis)

9.17 Genmark Diagnostics

9.18 Genomictree

9.19 HTG Molecular Diagnostics

9.20 Invitae

9.21 LabCorp

9.22 Myriad Genetics

9.23 Nanostring

9.24 Neogenomics

9.25 NSTG

9.26 Nuvera Biosciences

9.27 Orion Genomics

9.28 Pathway Genomics

10 Molecular Diagnostics in Cancer Testing Maufacturing Cost Analysis

10.1 Molecular Diagnostics in Cancer Testing Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

10.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Molecular Diagnostics in Cancer Testing Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Molecular Diagnostics in Cancer Testing Market Forecast (2017-2022)

14.1 Global Molecular Diagnostics in Cancer Testing Sales, Revenue and Price Forecast (2017-2022)

14.1.1 Global Molecular Diagnostics in Cancer Testing Sales and Growth Rate Forecast (2017-2022)

14.1.2 Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Molecular Diagnostics in Cancer Testing Price and Trend Forecast (2017-2022)

14.2 Global Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.1 United States Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.2 China Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.3 Europe Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 Japan Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Southeast Asia Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 India Molecular Diagnostics in Cancer Testing Sales, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Molecular Diagnostics in Cancer Testing Sales, Revenue and Price Forecast by Type (2017-2022)

14.4 Global Molecular Diagnostics in Cancer Testing Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Molecular Diagnostics in Cancer Testing

Table Classification of Molecular Diagnostics in Cancer Testing

Figure Global Sales Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Molecular Diagnostics in Cancer Testing

Figure Global Sales Market Share of Molecular Diagnostics in Cancer Testing by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Figure China Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Figure Europe Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Figure Japan Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Figure Southeast Asia Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Figure India Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Figure Global Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2022)

Figure Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2022)

Table Global Molecular Diagnostics in Cancer Testing Sales of Key Manufacturers (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Sales Share by Manufacturers (2012-2017)

Figure 2015 Molecular Diagnostics in Cancer Testing Sales Share by Manufacturers

Figure 2016 Molecular Diagnostics in Cancer Testing Sales Share by Manufacturers

Table Global Molecular Diagnostics in Cancer Testing Revenue by Manufacturers (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers (2012-2017)

Table 2015 Global Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers

Table 2016 Global Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers

Table Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Type (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Sales Share by Type (2012-2017)

Figure Sales Market Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)

Figure Global Molecular Diagnostics in Cancer Testing Sales Growth Rate by Type (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)

Figure Global Molecular Diagnostics in Cancer Testing Revenue Growth Rate by Type (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Regions (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Sales Share by Regions (2012-2017)

Figure Sales Market Share of Molecular Diagnostics in Cancer Testing by Regions (2012-2017)

Figure Global Molecular Diagnostics in Cancer Testing Sales Growth Rate by Regions (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Revenue and Market Share by Regions (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Revenue Share by Regions (2012-2017)

Figure Revenue Market Share of Molecular Diagnostics in Cancer Testing by Regions (2012-2017)

Figure Global Molecular Diagnostics in Cancer Testing Revenue Growth Rate by Regions (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Sales and Market Share by Application (2012-2017)

Table Global Molecular Diagnostics in Cancer Testing Sales Share by Application (2012-2017)

Figure Sales Market Share of Molecular Diagnostics in Cancer Testing by Application (2012-2017)

Figure Global Molecular Diagnostics in Cancer Testing Sales Growth Rate by Application (2012-2017)

Figure United States Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

Figure United States Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

Figure United States Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

Table United States Molecular Diagnostics in Cancer Testing Sales by Manufacturers (2012-2017)

Table United States Molecular Diagnostics in Cancer Testing Market Share by Manufacturers (2012-2017)

Table United States Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)

Table United States Molecular Diagnostics in Cancer Testing Market Share by Type (2012-2017)

Table United States Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)

Table United States Molecular Diagnostics in Cancer Testing Market Share by Application (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

Figure China Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Sales by Manufacturers (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Market Share by Manufacturers (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Market Share by Type (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)

Table China Molecular Diagnostics in Cancer Testing Market Share by Application (2012-2017)

Figure Europe Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

Figure Europe Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

Figure Europe Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

Table Europe Molecular Diagnostics in Cancer Testing Sales by Manufacturers (2012-2017)

Table Europe Molecular Diagnostics in Cancer Testing Market Share by Manufacturers (2012-2017)

Table Europe Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)

Table Europe Molecular Diagnostics in Cancer Testing Market Share by Type (2012-2017)

Table Europe Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)

Table Europe Molecular Diagnostics in Cancer Testing Market Share by Application (2012-2017)

Figure Japan Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

Figure Japan Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

Figure Japan Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

Table Japan Molecular Diagnostics in Cancer Testing Sales by Manufacturers (2012-2017)

Table Japan Molecular Diagnostics in Cancer Testing Market Share by Manufacturers (2012-2017)

Table Japan Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)

Table Japan Molecular Diagnostics in Cancer Testing Market Share by Type (2012-2017)

Table Japan Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)

Table Japan Molecular Diagnostics in Cancer Testing Market Share by Application (2012-2017)

Figure Southeast Asia Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

Figure Southeast Asia Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

Figure Southeast Asia Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

Table Southeast Asia Molecular Diagnostics in Cancer Testing Sales by Manufacturers (2012-2017)

Table Southeast Asia Molecular Diagnostics in Cancer Testing Market Share by Manufacturers (2012-2017)

Table Southeast Asia Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)

Table Southeast Asia Molecular Diagnostics in Cancer Testing Market Share by Type (2012-2017)

Table Southeast Asia Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)

Table Southeast Asia Molecular Diagnostics in Cancer Testing Market Share by Application (2012-2017)

Figure India Molecular Diagnostics in Cancer Testing Sales and Growth Rate (2012-2017)

Figure India Molecular Diagnostics in Cancer Testing Revenue and Growth Rate (2012-2017)

Figure India Molecular Diagnostics in Cancer Testing Sales Price Trend (2012-2017)

Table India Molecular Diagnostics in Cancer Testing Sales by Manufacturers (2012-2017)

Table India Molecular Diagnostics in Cancer Testing Market Share by Manufacturers (2012-2017)

Table India Molecular Diagnostics in Cancer Testing Sales by Type (2012-2017)

Table India Molecular Diagnostics in Cancer Testing Market Share by Type (2012-2017)

Table India Molecular Diagnostics in Cancer Testing Sales by Application (2012-2017)

Table India Molecular Diagnostics in Cancer Testing Market Share by Application (2012-2017)

Table Abbott Molecular Diagnostics Basic Information List

Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Accugenomics Basic Information List

Table Accugenomics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Accugenomics Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Agendia Basic Information List

Table Agendia Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Agendia Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Ambry Genetics Basic Information List

Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Ambry Genetics Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Biodesix Basic Information List

Table Biodesix Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Biodesix Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table bioMerieux Basic Information List

Table bioMerieux Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure bioMerieux Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table bioTheranostics (AviaraDx) Basic Information List

Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Cancer Genetics Basic Information List

Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Cancer Genetics Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Clarient, Inc. (GE Healthcare) Basic Information List

Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Counsyl Basic Information List

Table Counsyl Molecular Diagnostics in Cancer Testing Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Counsyl Molecular Diagnostics in Cancer Testing Global Market Share (2012-2017)

Table Flatiron Health Basic Information List

Table Epigenomics Basic Information List

Table Exact Sciences Corporation Basic Information List

Table Exiqon Basic Information List

Table Genomic Health Basic Information List

Table Genoptix (Novartis) Basic Information List

Table Genmark Diagnostics Basic Information List

Table Genomictree Basic Information List

Table HTG Molecular Diagnostics Basic Information List

Table Invitae Basic Information List

Table LabCorp Basic Information List

Table Myriad Genetics Basic Information List

Table Nanostring Basic Information List

Table Neogenomics Basic Information List

Table NSTG Basic Information List

Table Nuvera Biosciences Basic Information List

Table Orion Genomics Basic Information List

Table Pathway Genomics Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Molecular Diagnostics in Cancer Testing

Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing

Figure Molecular Diagnostics in Cancer Testing Industrial Chain Analysis

Table Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015

Table Major Buyers of Molecular Diagnostics in Cancer Testing

Table Distributors/Traders List

Figure Global Molecular Diagnostics in Cancer Testing Sales and Growth Rate Forecast (2017-2022)

Figure Global Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)

Table Global Molecular Diagnostics in Cancer Testing Sales Forecast by Regions (2017-2022)

Table Global Molecular Diagnostics in Cancer Testing Sales Forecast by Type (2017-2022)

Table Global Molecular Diagnostics in Cancer Testing Sales Forecast by Application (2017-2022)